European Journal of Nuclear Medicine and Molecular Imaging - Featured content on Alpha Particles Therapy
Please also check the respective themed section on issue level (see Issue 1/2022) at https://link.springer.com/journal/259/volumes-and-issues (this opens in a new tab). Here you will find all topical special issues or themed sections published so far.
King, A.P., Lin, F.I. & Escorcia, F.E.
Why bother with alpha particles?
Eur J Nucl Med Mol Imaging (2021)
https://doi.org/10.1007/s00259-021-05431-y (this opens in a new tab)
Sgouros, G., Frey, E., Du, Y. et al.
Imaging and dosimetry for alpha-particle emitter radiopharmaceutical therapy: improving radiopharmaceutical therapy by looking into the black box
Eur J Nucl Med Mol Imaging (2021)
https://doi.org/10.1007/s00259-021-05583-x (this opens in a new tab)
Sathekge, M.M., Bruchertseifer, F., Vorster, M. et al.
Global experience with PSMA-based alpha therapy in prostate cancer.
Eur J Nucl Med Mol Imaging (2021)
https://doi.org/10.1007/s00259-021-05434-9 (this opens in a new tab) and https://doi.org/10.1007/s00259-021-05531-9 (this opens in a new tab)
Jadvar, H., Colletti, P.M.
Targeted α-therapy in non-prostate malignancies.
Eur J Nucl Med Mol Imaging (2021)
https://doi.org/10.1007/s00259-021-05405-0 (this opens in a new tab)
Kratochwil, C., Apostolidis, L., Rathke, H. et al.
Dosing 225Ac-DOTATOC in patients with somatostatin-receptor-positive solid tumors: 5-year follow-up of hematological and renal toxicity
Eur J Nucl Med Mol Imaging (2021)
https://doi.org/10.1007/s00259-021-05474-1 (this opens in a new tab)
Hong, J.A., Brechbiel, M., Buchsbaum, J. et al.
National Cancer Institute support for targeted alpha-emitter therapy
Eur J Nucl Med Mol Imaging (2021)
https://doi.org/10.1007/s00259-021-05503-z (this opens in a new tab)